F279-0513 Screening compound: 6-{[2-(4-ethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

F279-0513 Screening compound: 6-{[2-(4-ethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one
F279-0513 Screening compound: 6-{[2-(4-ethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F279-0513
6-{[2-(4-ethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F279-0513

Molecular Formula

C20H20N4O4 (C20 H20 N4 O4)

Compound Name

6-{[2-(4-ethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-3,4-dimethyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

IUPAC name

6-{[2-(4-ethoxyphenyl)-5-methyl-13-oxazol-4-yl]methyl}-34-dimethyl-6H7H-[12]oxazolo[34-d]pyridazin-7-one

SMILES

CCOc(cc1)ccc1-c1nc(CN2N=C(C)c3c(C)onc3C2=O)c(C)o1

InChI

InChI=1S/C20H20N4O4/c1-5-26-15-8-6-14(7-9-15)19-21-16(12(3)27-19)10-24-20(25)18-17(11(2)22-24)13(4)28-23-18/h6-9H,5,10H2,1-4H3

InChI Key

PPWZQZYNSZBYMF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14947054

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.4

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.818

Distribution Coefficient, logD

2.818

Water Solubility, LogSw

-2.91

Polar Surface Area

74.208

Acid Dissociation Constant (pKa)

24.97

Base Dissociation Constant (pKb)

3.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

F279-0513 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer

References: we are preparing a list of scientific research reports with F279-0513 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F279-0513?
Check Price and Availability of F279-0513, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F279-0513 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F279-0513
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F279-0513
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F279-0513 available by request